Search results for "Infectious Disease"
Vital facts about vector-borne diseases
More than 700,000 people die of vector-borne diseases annually, according to data from the World Health Organization.
https://immattersacp.org/archives/2025/03/vital-facts-about-vector-borne-diseases.htm
1 Mar 2025
New findings on antiviral flu treatment
A recent study raises doubts about whether oseltamivir should be promoted as a way to prevent hospitalization in low-risk patients.
https://immattersacp.org/archives/2023/11/new-findings-on-antiviral-flu-treatment.htm
1 Nov 2023
Raising awareness about HPV-related cancers
The human papillomavirus (HPV) vaccine can potentially prevent more than 90% of HPV-associated cancers. Generally given to teens, it can be offered to adults as well.
https://immattersacp.org/archives/2023/10/raising-awareness-about-hpv-related-cancers.htm
1 Oct 2023
Prepare for next pandemic by training leaders
In response to the COVID-19 pandemic and the prospect of others, public health and medical groups are developing training initiatives to increase the numbers of infectious disease and public health specialists across the country.
https://immattersacp.org/archives/2023/03/prepare-for-next-pandemic-by-training-leaders.htm
1 Mar 2023
Improving HCV treatment and screening in primary care
Amid global calls to eliminate viral hepatitis, efforts are underway to screen asymptomatic adults for hepatitis C and overcome barriers to treatment.
https://immattersacp.org/archives/2022/01/improving-hcv-treatment-and-screening-in-primary-care.htm
1 Jan 2022
Applying ACP's advice for shorter courses of antibiotics
ACP's recent Best Practice Advice for antibiotic stewardship, the College's second guidance on the topic, is meant to improve patient care and combat antibiotic resistance.
https://immattersacp.org/archives/2021/10/applying-acps-advice-for-shorter-courses-of-antibiotics.htm
1 Oct 2021
Helping shield clinicians and the community from contagion
Face shields on top of masks may be another avenue in fighting the global COVID-19 pandemic.
https://immattersacp.org/archives/2020/07/helping-shield-clinicians-and-the-community-from-contagion.htm
1 Jul 2020
Testing offers hope, no panacea for COVID-19 control
A Q&A offers expert advice on the latest information about testing for COVID-19 from Elisa I. Choi, MD, FACP, Governor for ACP's Massachusetts Chapter and a fellow of the Infectious Diseases Society of America.
https://immattersacp.org/archives/2020/06/testing-offers-hope-no-panacea-for-covid-19-control.htm
1 Jun 2020
Working together to stop superbugs
The battle against antimicrobial resistance requires a broad line of attack, prompting the CDC to fund projects to expand regional efforts against multidrug-resistant organisms.
https://immattersacp.org/archives/2020/02/working-together-to-stop-superbugs.htm
1 Feb 2020
Uptake of herpes zoster vaccine linked to supply
Strong uptake led to short supply for the shingles vaccine. Learn how to educate patients and integrate best practices into your clinical routine.
https://immattersacp.org/archives/2019/10/uptake-of-herpes-zoster-vaccine-linked-to-supply.htm
1 Oct 2019
Screening, treatment of asymptomatic bacteriuria not needed for most, guideline states
The Infectious Diseases Society of America recommends screening and treatment only in pregnant women and in patients undergoing endoscopic urologic procedures associated with mucosal trauma.
https://immattersacp.org/weekly/archives/2019/03/26/2.htm
26 Mar 2019
Be proactive about managing hepatitis B
Reports and other guidance on both hepatitis B virus prevention and treatment all have reprised a common theme: Clearly vulnerable individuals are too often missed.
https://immattersacp.org/archives/2018/04/be-proactive-about-managing-hepatitis-b.htm
1 Apr 2018
New herpes zoster vaccine brings familiar challenges
A new vaccine should be considered the preferred option for prevention of shingles in adults and should be given in place of the existing one, but it brings with it familiar considerations: efficacy, insurance, and patient communication.
https://immattersacp.org/archives/2018/02/new-herpes-zoster-vaccine-brings-familiar-challenges.htm
1 Feb 2018
Recurrent C. difficile infections more than doubled between 2001 and 2012
Risk factors for recurrence include age; sex; and use of antibiotics, proton pump inhibitors, or corticosteroids. These factors could adjust treatment algorithms for high-risk patients, including earlier use of fecal transplant.
https://immattersacp.org/weekly/archives/2017/07/11/5.htm
11 Jul 2017
HIV and chronic HBV/HCV co-infection may increase non-Hodgkin's lymphoma risk
Co-infected patients with poor immune status or restoration are at high risk for non-Hodgkin's lymphoma and death and deserve high priority for access to well-tolerated, interferon-free, direct-acting antiviral treatment programs, study authors noted.
https://immattersacp.org/weekly/archives/2016/10/18/2.htm
18 Oct 2016
Tick-borne rickettsial disease recommendations updated by the CDC
Rickettsial diseases in the United States have increased during the past decade, according to a report, which notes that they continue to cause severe illness and death in otherwise healthy adults and children, despite the availability of effective antibacterial therapy.
https://immattersacp.org/weekly/archives/2016/05/24/4.htm
24 May 2016
Screen at-risk patients for syphilis, USPSTF draft statement recommends
The draft statement is open for public comment until Jan. 18.
https://immattersacp.org/weekly/archives/2015/12/22/5.htm
22 Dec 2015
CDC releases new treatment guidelines for STDs
Any patient who tests positive for chlamydia, gonorrhea, or trichomoniasis should be rescreened 3 months after treatment, according to the guidelines.
https://immattersacp.org/weekly/archives/2015/06/16/1.htm
16 Jun 2015
ACIP adds new vaccine to HPV recommendations
The Advisory Committee on Immunization Practices (ACIP) recommended the 9-valent human papillomavirus (HPV) vaccine (Gardasil 9) in last week's Morbidity and Mortality Weekly Report (MMWR).
https://immattersacp.org/weekly/archives/2015/03/31/4.htm
31 Mar 2015
Continuous PPI use associated with C. difficile recurrences
Recurrences of Clostridium difficile were significantly more common among patients who continuously took proton-pump inhibitors (PPIs) than among those who didn't, a recent study found.
https://immattersacp.org/weekly/archives/2015/03/10/5.htm
10 Mar 2015